prevention – Pharma GMP

Designing Effective CAPA for Repeated Manufacturing Events

digi — Tue, 25 Nov 2025 17:51:04 +0000

Designing Effective CAPA for Repeated Manufacturing Events Step-by-Step Tutorial: Designing Effective CAPA for Repeated Manufacturing Events Manufacturing deviations and CAPA (Corrective and Preventive Actions) are critical elements in pharmaceutical good manufacturing practice (GMP) that ensure product quality, patient safety, and regulatory compliance. In regulated environments such as those governed by FDA 21 CFR Parts 210/211,...

Cross Contamination Prevention in Pharmaceutical Manufacturing: GMP Perspective

digi — Mon, 24 Nov 2025 20:15:42 +0000

Cross Contamination Prevention in Pharmaceutical Manufacturing: GMP Perspective Comprehensive Step-by-Step Guide to Cross Contamination Prevention in Pharmaceutical Manufacturing Cross contamination prevention pharmaceutical manufacturing is a critical focus within Good Manufacturing Practice (GMP) to ensure patient safety, product quality, and regulatory compliance. The manufacturing environment for pharmaceutical products often handles multiple active pharmaceutical ingredients (APIs), formulations,...

FDA Data Integrity Warning Letters: Common Pitfalls and How to Avoid Them

digi — Sat, 15 Nov 2025 08:02:47 +0000

FDA Data Integrity Warning Letters: Common Pitfalls and How to Avoid Them Understanding FDA Data Integrity Warning Letters: A Comprehensive Step-by-Step Prevention Guide Ensuring trustworthy data is a fundamental requirement in pharmaceutical manufacturing and quality assurance. With increasing regulatory scrutiny, the United States Food and Drug Administration’s (FDA) focus on data integrity has resulted in...